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IN THE UNITED STATES DISTRICT COURT IN AND FOR 
DISTRICT OF UTAH, CENTRAL DIVISION 
SANMEDICA INTERNATIONAL, LLC, a 
Utah limited liability company; WESTERN 
HOLDINGS, LLC, a Nevada limited liability 
company, 
Plaintiffs, 
vs. 
AMAZON.COM, INC., a Delaware 
corporation, 
Defendant. 
COMPLAINT 
AND JURY DEMAND 
Case: 2:13-cv-00169 
Ass!gned To : Wells, Brooke C. 
Assrgn. Date: 03/06/2013 
Description: Sanmedica International et al 
v. Amazon. com 
Plaintiffs SanMedica International, LLC (SanMedica) and Western Holdings, LLC 
(Western) (together referred to as "Plaintiffs") complain against Defendant Amazon.com, Inc. 
(hereafter referred to as "Defendant") as follows: 
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INTRODUCTION 
Plaintiff Sanmedica markets and sells a product called Serovital™. Serovital is a patent-
pending dietary supplement that has been shown in a double-blind, placebo-controlled study to 
promote the human body's natural production of serum human growth hormone levels by a mean 
over baseline of over 600%. Although there are many products that claim to assist the body in 
producing growth hormone, Serovital is unique, because only it has been shown to be effective 
for both men and women of a wide age range. 1 
Defendant is a well-known internet retailer. Plaintiff Sanmedica offered to sell Serovital 
on the Amazon website. However, Amazon refused, claiming that it did not sell dietary 
supplement products that claimed to increase human growth hormone, like Serovital. 
In fact, Amazon does sell products that claim to increase HGH levels and compete with 
Serovital, including Original Formula GH3, Gerovital, AminoGH, Secratatropin HGH, Genf20 
Plus, Controlled Labs Blue Growth, Gerovital H3 Evolution, and HGH Complex. Furthermore, 
Amazon purchased advertisements with search engine providers, including Bing, Yahoo, and 
Google, which produce the following results listing for searches for "Serovital" and "Serovital 
hgh": 
Serovital-hgh at Amazon- Qualified orders over $25 ship free. 
Buy Serovital-hgh at Amazon! 
www.Amazon.com 
1 Plaintiff Western owns the intellectual property associated with Serovital, including the 
Serovital trademark. 
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Yet when the foregoing search listing for Amazon is clicked on, it takes the potential customer 
seeking Serovital to the Amazon.com site to a page that offers other competing dietary 
supplements for sale, but not Serovital. 
Amazon's advertisements constitute false and misleading statements that are likely to 
cause confusion and mistake among prospective buyers of Serovital. In fact, when typing the 
words "Serovital-HGH" into Bing and Yahoo, the Amazon result is often the first or second 
result on the page. And on Amazon's own drop-down search screen, when a consumer types in 
the word "Serovital" numerous other search terms appear including "Serovital hgh in health and 
personal care" and "Serovital hgh dietary supplement". However, when a consumer clicks on 
any of these links, products marketed by competitors of plaintiff appear for purchase. Defendant 
thus capitalizes on the goodwill of Plaintiffs scientifically supported product and carefully-
developed intellectual property in order to "bait" people searching for Plaintiffs' product into 
viewing Defendant's website, where Defendant is then able to "switch" the product purportedly 
being offered to products other than those marketed and sold by Plaintiffs. Defendant's actions 
are especially nefarious as it is using the name of Serovital, which is scientifically substantiated, 
to sell products that lack scientific support for their claims. This is therefore a classic bait and 
switch case-falsely claiming to have a superior product for sale in order to sell an inferior 
product. 
Defendant's actions violate the Lanham Act, various common law doctrines, and the 
Utah Truth in Advertising Act and entitle Plaintiff to the relief set forth below. 
PARTIES, JURISDICTION, AND VENUE 
1. Plaintiff Sanmedica International, LLC is a limited liability company organized 
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and existing under the laws of the State of Utah. Its principal place ofbusiness is located at 5742 
West Harold Gatty Drive in Salt Lake City, Utah. Sanmedica produces, markets, and sells 
Serovital. 
2. Plaintiff Western Holdings, L.L.C. is a limited liability company organized and 
existing under the laws of the state ofNevada. Its principal place of business is located at 1000 
East William Street, suite 204 Carson City, Nevada 89701. Western owns the trademark for 
Serovital and copyrights to its packaging, along with all other intellectual property associated 
with Serovital. Western licenses the use of its intellectual property to Sanmedica to produce, 
market, and sell Serovital. 
3. Defendant Amazon. com, Inc. is, on information and belief, a corporation 
organized and existing under the laws of the state ofDelaware. Its principal place ofbusiness is 
located in Seattle, Washington 98144. 
4. Subject matter jurisdiction over this action is conferred upon this Court by 28 
U.S.C. § 1338 and the Lanham Act, 15 U.S.C. § 1121. 
5. This Court has supplemental jurisdiction over Plaintiffs' state-law claims pursuant 
to 28 U.S.C. § 1367, in that the state law claims are integrally related to the federal claims and 
arise from a common nucleus of operative facts, such that the resolution of all claims herein is in 
the interests of judicial economy. 
6. The Court has personal jurisdiction over Defendant pursuant to the Utah Long 
Arm Statute, Utah Code Ann.§ 78B-3-201 because Defendant has (a) transacted business in this 
State and (b) engaged in tortious activity causing injury in this state. Specifically, the Defendant 
has falsely advertised Plaintiffs' Serovital product for sale in the state ofUtah when it does not in 
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fact offer it for sale, and transacts business generally within the state of Utah by selling and 
supplying goods to the residents of the state of Utah. Furthermore, the Defendants have caused 
injury to the Plaintiffs in the State of Utah. 
7. Venue is proper in this Court pursuant to 28 U.S.C. § 1391(b) and (c). 
GENERAL ALLEGATIONS 
The Product 
8. Plaintiff Sanmedica is engaged in the business of marketing, selling and 
developing dietary and health supplements. 
9. PlaintiffSanmedica offers a 100% money-back guarantee to any consumer who is 
dissatisfied with the product for any reason. In compliance with the guarantee, customers need 
only return the unused portion for a full refund. Plaintiff always honors and fulfills its 100% 
money-back guarantee in accordance with the terms of its guarantee. 
10. Plaintiff Sanmedica sells Serovital directly to consumers through its internet 
websites and call center, and to retailers that market and sell to consumers throughout the United 
States. 
11. Plaintiff Sanmedica advertises and promotes its products in numerous print, 
electronic, and broadcast media in national circulation and on its own websites. 
12. Plaintiff Sanmedica markets and sells Serovital through the national retailer Ulta, 
and is in the process of expanding to other national retailers. 
13. Plaintiffs Sanmedica and Western have expended a great deal of time, effort, and 
money to develop, study, market, advertise, and promote Serovital. 
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14. In 2011, Sanmedica funded research at Pennington Biomedical Research Center 
at Louisiana State University, one of the premier medical research institutes in the United States, 
on the patent-pending formulation for Serovital. 
15. On January 14, 2012, Sanmedica received the results ofthe study. 
16. The study was a cross-over, placebo-controlled randomized study. Sixteen 
healthy subjects had serum GH measured at baseline and 15, 30, 60, 90 and 120 minutes after 
taking a single dose of Serovital or placebo. 
17. After 120 minutes, GH levels had increased 8-fold from baseline and were 
significantly higher than placebo. In addition, a significantly higher mean area under the curve 
(AU C) was observed after taking the supplement. 
18. Thus, the study showed that a single oral dose of Serovital can significantly 
increase GH Levels after 120 minutes in healthy men and women. 
19. No other so-called HGH dietary supplements, including the products advertised 
on Amazon, have studies like the Pennington study supporting their claims. 
20. On September 20-24, 2012, Sanmedica presented the results ofthe Pennington 
study at the annual conference of the Obesity Society in San Antonio, Texas. 
21. The results of the Pennington study were so compelling that Dr. Oz, the well-
known television personality, featured the study on his national television program on October 
31, 2012. 
22. Over the past year, there have been significant media coverage of HGH, such that 
the consuming public has become much more informed about the positive health benefits of 
HGH. 
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23. The Plaintiffs products have developed a reputation of high quality and goodwill 
in the industry and the consuming public. 
24. The Serovital trademark was first used in interstate commerce on September 14, 
2012. An application for registration of that trademark was filed in the United States Patent and 
Trademark Office (the "USPTO") on March 5, 2012. The trademark was published for 
opposition by the USPTO on December 18,2012 (a true and correct copy of a status report 
regarding the trademark is attached hereto as Exhibit "A"). Plaintiffs are unaware of any 
opposition to said trademark registration that has been timely filed with the USPTO or any other 
claims of competing rights to said product by any other persons or entities. On February 14, 
2013 the USPTO issued a notice of allowance. On March 6, 2013, Western filed a notice of use. 
Western expects to the USPTO to issue a notice that the Serovital mark has registered shortly. 
25. Serovital is an arbitrary word chosen by Plaintiff Western as its trademark due to 
its uniqueness. 
26. Plaintiffs have expended a great deal of time, effort, and money developing its 
intellectual property rights in connection with Serovital™ including the trademark, packaging 
trade dress, copyrighted label, copyrighted package insert, and copyrighted advertisements that 
have appeared in numerous newspapers and magazines, as well as on Plaintiffs Web sites (e.g., 
www.Serovital.com). 
Defendant's Internet Advertising 
27. Defendant has entered into financial arrangements with various internet search 
engine providers, including without limitation, Bing, Yahoo, and Google, to direct searches of 
keywords "Serovital" and "Serovital hgh" to a list of search results that prominently produces a 
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sponsored advertisement by Defendant that states the Defendant offers to sell Serovital, with the 
following language: 
Serovital-hgh at Amazon- Qualified orders over $25 ship free. 
Buy Serovital-hgh at Amazon! 
www.Amazon.com 
Copies of said search results pages from Bing and Yahoo are attached hereto respectively as 
Exhibits "B" and "C". 
28. Despite the representations ofDefendant's sponsored advertisement purporting to 
offer Serovital for sale to the customers seeking that specific product, when the search listing for 
Amazon.com is clicked on, it takes the customer to Defendant's website to search results that 
offer for sale other products, including Original Formula GH3, Gerovital, AminoGH, 
Secratatropin HGH, Genf20 Plus, Controlled Labs Blue Growth, Gerovital H3 Evolution, and 
HGH Complex, but not Serovital. Copies of the search results on Defendant's website for 
keywords "Serovital" and "Serovital hgh" are respectively attached hereto as Exhibits "D" and 
"E.'' 
29. In addition, when a potential customer types the word "Serovital" or "Serovital 
HGH" on the Amazon Website, a drop-down screen appears offering suggested search terms, all 
of which include the Serovital trademark. The suggested search terms include "Serovital HGH 
in dietary supplements" and "Serovital in Books". When a customer clicks on one of the 
suggested search terms, products are offered for sale. However, none of the products are 
Serovital. 
30. Plaintiffs have not granted Defendant and Defendant has no right to use the 
Serovital trademark on its website or to advertise it for sale, especially since Defendant has no 
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intent to sell Serovital on its website. A copy of the Amazon page suggested search terms are 
attached as Exhibit "F". 
31. Rather, Defendant, by falsely advertising that Serovital is available for purchase 
on its website, capitalizes on the goodwill of plaintiffs product and trademark in order to '·bait" 
prospective customers searching specifically for Serovital or Serovital-HGH to Defendant's 
website, where Defendant can then "switch" the product falsely being advertised for sale to other 
products marketed and sold by Defendant. This is a classic bait and switch case. 
32. On January 28, 2013, PlaintiffSanmedica sent a written notice to the Registered 
Agent for Amazon.com, Inc., pursuant to the Utah Truth in Advertising Act (the "UT AA''), Utah 
Code Ann. §13-lla-4(5), giving notice to Defendant that is was in violation ofthe provisions of 
UT AA by using deceptive, misleading, and false advertising practices relating to the purported 
sale of Serovital on Defendant's website. As required by the UTAA, Plaintiffs notice ( a copy 
of which is attached hereto as Exhibit "G") demanded that Defendant, within 10 days of receipt 
of said notice: (a) remove all advertisements on the internet that advertise, offer, state, or imply 
in any way that Defendant carries or offers for sale Serovital; (b) promulgate a correction notice 
with the same search engine providers containing the deceptive advertisements that states that 
Serovital is not offered for sale by Defendant; and (c) send written proof of its compliance with 
the demand to Plaintiff with the 1 0-day period. 
33. Defendant has failed to provide proof that it has complied with the demands ofthe 
notice attached hereto as Exhibit "G." And Defendant continues to falsely advertise Serovital for 
sale as alleged above and to infringe on Plaintiffs trademark by using that trademark in 
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advertisements placed through search engine providers in a manner likely to cause confusion, 
mistake or to deceive the public. 
FIRST CLAIM FOR RELIEF 
(Trademark Infringement under the Lanham Act) 
34. Plaintiffs re-allege and incorporate by reference paragraphs 1 through 33 above, 
as though set forth fully in this count. 
35. PlaintiffWestern is the current, active, and exclusive owner ofSerovital's™ valid 
and legally protected trademark, trade dress, and copyright. The trademark is active, valid and 
has not been revoked or canceled. In addition, the trademarked term is an arbitrary word chosen 
by Plaintiff Western as its trademark due to its uniqueness. 
36. Defendant has used and is continuing to use Plaintiff Western's trademark in 
commerce without consent, and Defendant's use is likely to deceive, cause confusion, or result in 
mistake as to the affiliation, connection, or association of Defendant with Plaintiffs Western and 
Sanmedica and as to the availability of Serovital on Defendant's website. 
37. Defendant's unauthorized use ofPlaintiffWestern's trademark has damaged and 
materially diminished the value ofPlaintiffWestern's trademark rights, and interfered with 
Plaintiff Western and Sanmedica' s existing and potential business relations. 
38. Defendant's unauthorized use of the Serovital trademark has infringed upon 
Plaintiff Western's trademark and trade name rights, in violation of 15 U.S.C. §§ 1114 and 
1125(a). 
39. As a result of Defendant's conduct, Plaintiffs Western and Sanmedica have 
suffered damages that include but are not limited to lost sales of its product, trademark 
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infringement and dilution, and damage to Plaintiffs' existing and potential business relations, 
together with costs ofthis action. In addition, pursuant to 15 U.S.C. § 1117(a), Plaintiffs are 
entitled to an award of attorneys' fees since Defendant's acts are willful, intentional, and 
egregious, making this an exceptional case. 
SECOND CLAIM FOR RELIEF 
(Unfair Competition Based on False Representations in violation of Lanham Act 15 U.S.C. 
§ 1125(a)(l)(A)) 
40. Plaintiffs re-allege paragraphs 1 through 39 of this Complaint as if set forth in full 
herein. 
41. Defendant has without authorization, on or in connection with the promotion and 
sale of its goods in interstate commerce, made or contributed to the making of representations of 
fact that are false and misleading which are likely to cause confusion, or to cause mistake, or to 
deceive purchasers and potential purchasers into believing that Plaintiffs' product, Serovital, is 
available for purchase from Defendant. 
42. Defendant's acts constitute unfair competition and are misleading representations 
of facts. 
43. Upon information and belief, Defendant's acts of unfair competition and 
misrepresentations have led to, among other things, initial interest confusion in consumers 
stemming from Defendant's "bait and switch" practices. 
44. Upon information and belief, Defendant's acts of unfair competition and 
misrepresentations have deceived and, unless restrained, will continue to deceive the public, 
including consumers and retailers, and have injured and unless constrained will continue to 
injure Plaintiffs and the public, including consumers and retailers, causing damages to Plaintiffs 
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in an amount to be determined at trial and other irreparable injury to the goodwill and reputation 
of Plaintiff and its product, Serovital. 
45. Upon information and belief, Defendant's acts of unfair competition are willful, 
intentional and egregious and make this an exceptional case within the meaning of 15. U.S.C. 
§ 1117(a), entitling Plaintiffs to attorney's fees. 
46. Plaintiffs have no adequate remedy at law to compensate them for all the damages 
the Defendant's wrongful acts have and will cause. 
herein. 
THIRD CLAIM FOR RELIEF 
(Unjust Enrichment) 
4 7. Plaintiff realleges paragraphs 1 through 46 of this Complaint as if set forth in full 
48. Defendant has benefited from the use of Plaintiffs' name, reputation, and 
goodwill without compensating the Plaintiffs. 
49. Defendant's conduct, directly or through an agent or affiliate, constitutes unjust 
enrichment to the Defendant. 
50. By virtue of Defendant's unjust enrichment, Plaintiffs have suffered money 
damages. 
herein. 
Act. 
FOURTH CLAIM FOR RELIEF 
(Injunctive RelieD 
51. Plaintiffs re-allege paragraphs 1 through 50 of this Complaint as if set forth in full 
52. Defendant has engaged in deceptive trade practices in violation of the Lanham 
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53. Defendant's acts will continue to deceive the public, including consumers and 
retailers, unless the Court enjoins Defendant from advertising, marketing, or purporting to sell 
Serovital-that it in fact has no intention to sell-or from engaging in any other false advertising 
with regard to Plaintiffs' products or engaging in any other unfair competition based upon false 
and misleading or confusing statements related to Serovital. 
herein. 
FIFTH CLAIM FOR RELIEF 
(Declaratory RelieD 
54. Plaintiffs re-allege paragraphs 1 through 53 of this Complaint as if set forth in full 
55. Based on the allegations contained in this Complaint, there is a present and actual 
need for a judicial declaration. 
56. Pursuant to the Declaratory Judgment Act, 28 U.S.C. § 2201, Plaintiffs are 
entitled to and hereby move the Court for a judgment declaring that: 
a. Defendant's advertising is illegal, confusing, likely to confuse or 
otherwise misleading. 
b. Plaintiffs have a legally protectable interest in preventing Defendant's 
advertising. 
c. Plaintiffs have suffered real harm as a result of Defendant's advertising. 
d. Defendant's advertising is likely to confuse the public into believing that 
the Defendant is authorized to sell Serovital and/or that the public may in fact order 
Serovital through Defendant's website. 
e. Defendant should pay Plaintiffs their attorney fees and costs incurred in 
prosecuting this action. 
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SIXTH CLAIM FOR RELIEF 
(Violation of Utah Truth in Advertising Act) 
57. Plaintiffs re-allege paragraphs 1 through 56 of this Complaint as if set forth in full 
herein. 
58. Defendant's advertisements as alleged above are deceptive practices under the 
Utah Truth in Advertising Act, Utah Code Ann. § 13-1 a-3 (the "UT AA"), since they cause the 
likelihood of confusion or of misunderstanding by advertising the sale of Serovital on 
Defendant's website, without intending to sell them to the public. 
59. The advertisements alleged above were made in and to residents of the state of 
Utah. 
60. Plaintiffs have suffered damages as a result of the misleading and false 
advertisements of Defendant and will continue to suffer damage unless the Court enjoins 
Defendant from advertising, marketing, or purporting to sell Serovital or from engaging in any 
other false advertising with regard to Plaintiffs' product or engaging in any other unfair 
competition based upon false and misleading or confusing statements related to Serovital. 
61. In addition to injunctive relief under the UT AA, Plaintiffs are entitled to recover 
actual damages it sustains as a consequence of Defendant's violation of the UTAA, together with 
costs and attorney's fees incurred in bringing this claim. 
62. Pursuant to the UT AA, Plaintiffs are entitled to statutory damages of $2,000.00 
per violation, or in other words, Plaintiffs are entitled to $2,000.00 for each potential customer 
who clicked on an offending link. 
PRAYER FOR RELIEF 
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WHEREFORE, Plaintiffs respectfully request the following relief: 
A. A permanent injunction against Defendant, its officers, agents, servants, 
employees, and attorneys, and upon those persons in active concert or participation with them 
who receive actual notice of the injunction by personal service or otherwise, enjoining and 
restraining them from directly or indirectly: 
1. Advertising, marketing, or offering to sell Serovital in any source, 
including any internet search engine provider, or in any manner on Defendant's website; 
or 
2. Publishing, displaying, distributing, disseminating or using, or permitting 
or entering into or performing any agreement for the publication, display, distribution, or 
use of Plaintiffs' trademarked name, Serovital. 
B. An order requiring Defendant to immediately remove, or cause to be removed, all 
advertisements that purport to or imply that Defendant sells Serovital on its website. 
C. Judgment on all claims for the damages suffered by Plaintiffs as a result of 
Defendant's unfair competition and deceptive acts and practices, in an amount to be determined 
at trial. 
D. Judgment on the First, Second, and Sixth Claims for Relief awarding Plaintiff 
reasonable attorney's fees in this action, pursuant to 15 U.S.C. § 1117 and Utah Code Ann. §13-
lla-4, respectively. 
E. Judgment awarding statutory damages under the Plaintiffs' UTAA claim. 
F. Judgment awarding Defendant's profits to Plaintiffs, and awarding damages 
sustained by the Plaintiffs and the costs of the action. 
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G. Judgment for punitive damages as a result of Defendant's outrageous conduct and 
willful and intentional violations. 
H. Judgment on all claims awarding Plaintiffs costs and attorney's fees in this action. 
I. Declaratory relief as requested. 
J. Injunctive Relief as requested. 
K. Such other relief as the Court may deem just and equitable. 
DEMAND FOR JURY TRIAL 
Plaintiffs demand a trial by jury of all matters that may be tried by a jury. 
DATED this ~ r day ofMarch, 2013. 
PRICE PARKINSON & KERR, PLLC 
By: 
Mark J. Williams 
Jason M. Kerr 
Attorneys for Plaintiffs 
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